sources say the agency is expected to make a broad authorization as soon as this week. nih has presented evidence from an ongoing study showing it doesn t matter which vaccine they get, that mixing doses is safe and boosts immune response. peter hotez is the co-director for the center for vaccine development at children s hospital. what do you think of this? all good news? yeah. on the other hand, kate, what i would say is there are really not too many instance where is i think it would be necessary to make a switch. the reason i say that is an abundance of the three different types of vaccines available in the united states, and, you know, there may be some parts of the u.s. where one is limited and you can t get it, but generally speaking they re widely available. let s go through this one by one. the first two doses of the pfizer/biontech vaccine which i got, i stuck with pfizer, the reason being because there s always going to be more data on a vaccine coming from the same compan
doctor, always a pleasure to speak to you. you will be considering booster for johnson & johnson and moderna. we ll see that s where this is headed. i think one of the more interesting discussions that will come up is new research on mixing doses for the boosters. if you have had johnson & johnson, getting moderna with joh johnson and johnson. it will be a discussion that happens on friday afternoon. and i think why it might be advantageous, there was recently a study in the new england journal of medicine looking at people who got the astrazeneca, similar to the johnson & johnson vaccine. they divided them in half. one half got the second dose of as extra zeneca and the second